Emergent Biosolutions, Inc. (EBS) Stock Price, Quote & AI Analysis

Live EBS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Emergent Biosolutions, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Emergent Biosolutions, Inc. (EBS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

EBS
Emergent Biosolutions, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
11.330000
High
11.850000
Low
11.280000
Volume
485,397
VWAP
-
Market Cap
$595,576,391.76
52W Range
$4.02 - $14.06
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Mar 2, 2026 Q4
After Hours
EPS Estimate: $0.1111
Revenue Estimate: $219,675,000.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Emergent Biosolutions, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Emergent Biosolutions, Inc. Overview

Company information

Company Overview

Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures. It operates through the following segments: Commercial Product Sales, MCM Product Sales, and Services. The Commercial Product Sales segment includes NARCAN products and other commercial products that were sold as part of the travel health business. The MCM Product Sales segment focuses on the Anthrax - MCM products, Smallpox - MCM products and other products. The Services segment consists of the company’s Bioservices offerings. It offers products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The company was founded by Fuad El-Hibri on September 5, 1998 and is headquartered in Gaithersburg, MD.

Company Details
Market Cap
$614.48M
Shares Outstanding
52,520,000
Weighted Shares Outstanding
52,519,964
CEO
Joseph C. Papa
Address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
Employees
900
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Emergent Biosolutions, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...